Pelvic Floor DisordersNCT06808542
Pelvic Floor Dysfunction Among Female Physiotherapy Students: A Cross-Sectional Study
An observational study of Pelvic Floor Disorders, run by Cairo University at 1 site in Egypt.
Trial summary
This study aims to: 1. estimate the prevalence of pelvic floor dysfunction among female physiotherapy students at Cairo University. 2. identify potential risk factors that may be associated with pelvic floor dysfunction in this student population. 3. Read more about this study
- Who is it for?
- Ages 18 to 25 years, women only
- Conditions the study is for
- Pelvic Floor Disorders
- How many people
- 180 participants
- Where
- 1 siteEgypt
- Study dates
- 4 Feb 2025to 25 Apr 2025
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- Women only
- Adult
Study population: This study aims to enrol a sample of 180 female physiotherapy students from Cairo University, from the first-year to the fifth-year levels, to ensure adequate representation across different stages of the academic program.
Who may be able to join
- Virgin undergraduate physiotherapy students.
- Their age will range from 18-25 years.
Who cannot join
- Neurological disorders or injuries that may affect pelvic floor function (e.g., fibromyalgia and multiple sclerosis).
- Mental health or cognitive disorders that could affect data collection.
- Females who have undergone any form of abdominal surgery prior to the time of the study.
- Females with current use of medications that may affect pelvic floor function (e.g., anticholinergics, opioids, antidepressants).
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Amira Nagy Abdellatif Hamad, PhD contact
Egypt1 site, 1 recruiting
- Recruiting
Cairo University
Giza
Doaa A. Osman, PhD, 01115792245, Doaa.osman@cu.edu.eg
Amira Nagy Abdellatif Hamad, PhD
About this study
This study aims to:
- estimate the prevalence of pelvic floor dysfunction among female physiotherapy students at Cairo University.
- identify potential risk factors that may be associated with pelvic floor dysfunction in this student population.
- assess the level of awareness regarding pelvic floor health among female physiotherapy students at Cairo University.
- explore how female physiotherapy students at Cairo University utilize available healthcare resources for managing pelvic floor-related concerns.
Read the detailed description
Pelvic floor dysfunction (PFD) is a global health problem that affects millions of women worldwide. It encompasses a broad range of interrelated disorders affecting the pelvic region, including urinary incontinence, pelvic pain, constipation, sexual dysfunction, and pelvic organ prolapse. While PFD is often associated with pregnancy, childbirth, and aging, recent studies suggest that these conditions may also affect younger populations, including nulliparous women.
Pelvic floor health is crucial for supporting pelvic organs, maintaining continence, and facilitating sexual function. However, the impact of PFD on women's health and quality of life is significant, with important consequences for physical and mental well-being. These disorders often coexist and compound each other's impact, leading to disabling symptoms, embarrassment, social isolation, impaired task performance, loss of personal and intimate relationships, and reduced participation in leisure activities.
Despite the substantial burden of PFD, there is a lack of comprehensive data on the prevalence, risk factors, and awareness levels of these conditions among specific populations, particularly young women pursuing higher education. Physiotherapy students, who are expected to have a good understanding of musculoskeletal and pelvic health, represent an important group to study in this context.
- Conditions
- Pelvic Floor Disorders
- Being tested
- No intervention
- Medical subject headings
- Pelvic Floor Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No interventionOther
No intervention
What is being measured
The primary outcome is the main question the study is designed to answer.
Modified Australian pelvic floor questionnaire
It will be used to estimate the prevalence of pelvic floor disorders through assessing their bladder function, bowel function, and pelvic organ prolapse. This questionnaire will be administered electronically via online survey platforms.
Measured: 2 months
Secondary outcomes (1)
A self-administered survey
A self-administered survey will be used to assess potential associated risk factors, including lifestyle habits, weight, BMI, family history, mental health factors (stress, anxiety, depression), physical health factors (sleep, exercise, dietary habits). Also, it will assess students' awareness of pelvic floor health and their utilization of available healthcare resources for managing pelvic floor-related concerns.
Measured: 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Feb 2025
- Study start4 Feb 2025
- Primary completion4 Apr 2025 (estimated)
- Study completion25 Apr 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pelvic Floor DisordersStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 180 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Doaa A. Osman, Cairo University
- Investigators
- Doaa A. Osman, PhD, Study chair, Assistant Professor, Cairo university
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06808542
- Sponsor's protocol ID
- P.T.REC/012/005385
- Status last verified
- Feb 2025
- First submitted
- 30 Jan 2025
- Last updated
- 25 Feb 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No